Not Yet Rated
0 stars


For Purchase


Support and Documentation

New Strategies

AX for Pharma for Microsoft Dynamics AX

by New Strategies

A complete ERP solution for the pharmaceutical industry, New Strategies AX for Pharma is built on the Microsoft Dynamics AX platform and utilizes leading Microsoft technologies to deliver a solution that is proven, innovative, and backed by one of the world’s largest enterprise software providers. AX for Pharma is available for both Microsoft Dynamics AX 2012 and AX 2009.

The solution enhances robust, Role Tailored ERP capabilities and builds in additional functionality to give pharmaceutical companies a single, integrated solution that covers processes from research and development to sales, planning, purchasing, production, quality management and plant maintenance.

Designed for straightforward implementations, minimal customizations, and FDA validation, AX for Pharma enables enterprise and mid-sized companies to:

- Work with a system that combines Microsoft Dynamics AX with industry-specific capabilities and modules that include a Manufacturing Execution System, Advanced Quality Management, and Enterprise Asset Management.
- Achieve full compliance with international guidelines and regulations, and drive consistent compliance by tracking GMP operations such as lot status, work order processing, batch releases, and quality control approvals.
- Integrate advanced quality assurance and control, including non-conformance management, quarantine orders, quality orders, sampling plans, reduced/skip testing, acceptance criteria, certificates of analysis, and batch records.

AX for Pharma enforces GMP guidelines and regulations like 21 CFR Part 11 for operations and supply chain management to support rework activities, co/by- products, contract manufacturing, in process controls, container/sub-lot management, sample management and advanced quality management.

AX for Pharma for Microsoft Dynamics AX has not been reviewed by any customers.

Submit A Review

The views and opinions submitted and expressed here are not those of Microsoft.